Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial-Reference-Cited by-同舟云学术

Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial

Published:2024-01 Issue:1 Volume:12 Page:67-77
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Ramakrishnan Sanjay,Jeffers Helen,Langford-Wiley Beverly,Davies Joanne,Thulborn Samantha J,Mahdi Mahdi,A'Court Christine,Binnian Ian,Bright Stephen,Cartwright Simon,Glover Victoria,Law Alison,Fox Robin,Jones Adam,Davies Christopher,Copping David,Russell Richard EK,Bafadhel Mona

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference29 articles.

1. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids;Schols;Eur Respir J,2001

2. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study;Waljee;BMJ,2017

3. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease;Walters;Cochrane Database Syst Rev,2014

4. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease;Aaron;N Engl J Med,2003

5. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial;Leuppi;JAMA,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valoración del recuento sanguíneo de eosinófilos en la patología respiratoria desde atención primaria;Medicina de Familia. SEMERGEN;2024-09

2. Managing and discharging COPD patients hospitalized because of an exacerbation of respiratory symptoms: An opportunity to improve outcomes;European Journal of Internal Medicine;2024-09

3. Potential for personalised and biomarker-guided COPD self-treatment approaches;The Lancet Respiratory Medicine;2024-08

4. Exacerbations of bronchiectasis;European Respiratory Review;2024-07

5. Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study;American Journal of Respiratory and Critical Care Medicine;2024-07-01